Teriparatide API (CAS No. 52232-67-4) is a recombinant human parathyroid hormone (PTH) analog consisting of the first 34 amino acids of the endogenous PTH. It is produced via recombinant DNA technology, typically using E. coli expression systems.

Key Features:

• High Purity: Manufactured to comply with pharmacopeial standards (CP/EP), ensuring minimal impurities.

• Bioactivity: Acts as an anabolic agent, stimulating osteoblast activity and bone formation.

• Applications: Treats osteoporosis (postmenopausal women, men at high fracture risk) and glucocorticoid-induced osteoporosis.

• Quality Assurance: Produced under cGMP; rigorously tested for identity, potency, sterility,endotoxins, and residual solvents.

• Storage: Stable at 2–8°C; protect from light and freezing.

  This API is critical for bone health therapies, offering targeted anabolic effects with strict adherence to safety and regulatory guidelines.